Siqi Wen

404 total citations
19 papers, 297 citations indexed

About

Siqi Wen is a scholar working on Cancer Research, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Siqi Wen has authored 19 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Siqi Wen's work include Cancer, Hypoxia, and Metabolism (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Ubiquitin and proteasome pathways (3 papers). Siqi Wen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Ubiquitin and proteasome pathways (3 papers). Siqi Wen collaborates with scholars based in China, Belarus and Saudi Arabia. Siqi Wen's co-authors include Cheng‐He Zhou, Ling Zhang, Ponmani Jeyakkumar, Srinivasa Rao Avula, Xianquan Zhan, Chao Luo, Dinesh Addla, Tianyu Long, Swetha Kameswari Maddili and Wei‐Wei Gao and has published in prestigious journals such as Resources Conservation and Recycling, Urology and Frontiers in Pharmacology.

In The Last Decade

Siqi Wen

19 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siqi Wen China 8 131 85 36 35 28 19 297
Amr Hassan Egypt 13 231 1.8× 66 0.8× 14 0.4× 26 0.7× 14 0.5× 25 482
Parisa Ghanbari Iran 8 202 1.5× 92 1.1× 18 0.5× 18 0.5× 12 0.4× 14 409
Yasuo Nakayama Japan 10 129 1.0× 45 0.5× 50 1.4× 25 0.7× 50 1.8× 32 484
Badriya Baig United Arab Emirates 5 143 1.1× 16 0.2× 56 1.6× 17 0.5× 36 1.3× 7 311
Birte Plitzko Germany 10 160 1.2× 22 0.3× 17 0.5× 31 0.9× 31 1.1× 11 323
Md. Saiful Islam United Kingdom 7 365 2.8× 35 0.4× 34 0.9× 116 3.3× 32 1.1× 16 495
Fátima Liliana Monteiro Portugal 9 170 1.3× 83 1.0× 16 0.4× 41 1.2× 20 0.7× 15 349
Xiaowen Zou China 11 168 1.3× 76 0.9× 27 0.8× 47 1.3× 14 0.5× 18 355

Countries citing papers authored by Siqi Wen

Since Specialization
Citations

This map shows the geographic impact of Siqi Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Wen more than expected).

Fields of papers citing papers by Siqi Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siqi Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Wen. The network helps show where Siqi Wen may publish in the future.

Co-authorship network of co-authors of Siqi Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Siqi Wen. A scholar is included among the top collaborators of Siqi Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siqi Wen. Siqi Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Tianyu, Xiang Li, Min Lin, et al.. (2025). SREBP2 as a central player in cancer progression: potential for targeted therapeutics. Frontiers in Pharmacology. 16. 1535691–1535691. 1 indexed citations
2.
Wen, Siqi, et al.. (2025). The Ubiquitin–Proteasome System in Asthma: Mechanisms and Therapeutic Possibilities. Clinical Reviews in Allergy & Immunology. 68(1). 86–86. 1 indexed citations
3.
Zhang, Man, et al.. (2024). Emerging role of SENP1 in tumorigenesis and cancer therapy. Frontiers in Pharmacology. 15. 1354323–1354323. 2 indexed citations
4.
Shen, Yuanyuan, et al.. (2024). “Discovering shine through feedback seeking”---feedback seeking among new graduate nurses: a qualitative study. BMC Nursing. 23(1). 10–10. 5 indexed citations
5.
Wen, Siqi, et al.. (2024). Work–family conflict categories and support strategies for married female nurses: a latent profile analysis. Frontiers in Public Health. 12. 1324147–1324147. 7 indexed citations
6.
7.
Tang, Yuan Yan, et al.. (2022). Effects of baffle and intraocular pressure on aerosols generated in the noncontact tonometer measurement during COVID-19. International Journal of Ophthalmology. 15(4). 533–540. 1 indexed citations
8.
Zhan, Xianquan, Miaolong Lu, Jingru Yang, et al.. (2022). Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. Frontiers in Endocrinology. 13. 970843–970843. 4 indexed citations
9.
Chang, Liao, et al.. (2021). Evaluation of a Custom SNP Panel for Identifying and Rectifying of Misjudged Paternity in Deficiency Cases. Frontiers in Genetics. 12. 602429–602429. 5 indexed citations
10.
Li, Na, Nannan Li, Siqi Wen, et al.. (2021). HSP60 Regulates Lipid Metabolism in Human Ovarian Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 6610529–6610529. 16 indexed citations
11.
Li, Biao, Xiaowei Wang, Chenguang Yang, et al.. (2021). Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches. The EPMA Journal. 12(1). 67–89. 16 indexed citations
12.
Shi, Wenwen, Bo Dou, Jun Wang, et al.. (2021). XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis. Frontiers in Oncology. 11. 654995–654995. 21 indexed citations
13.
Wen, Siqi, Jiajia Li, Jingru Yang, et al.. (2021). Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors. Frontiers in Endocrinology. 12. 753606–753606. 10 indexed citations
14.
15.
Wen, Siqi, et al.. (2021). Improving the efficiency of wastewater treatment and microalgae production for biofuels. Resources Conservation and Recycling. 178. 106094–106094. 34 indexed citations
16.
Zhang, Liyuan, Xiaokang Zhang, Jie Yang, et al.. (2020). A Novel Approach for Repairing Superior Mesenteric Artery Injury During Left Nephrectomy—6-year Follow-up. Urology. 144. 241–244. 2 indexed citations
17.
18.
Wen, Siqi, Ponmani Jeyakkumar, Srinivasa Rao Avula, Ling Zhang, & Cheng‐He Zhou. (2016). Discovery of novel berberine imidazoles as safe antimicrobial agents by down regulating ROS generation. Bioorganic & Medicinal Chemistry Letters. 26(12). 2768–2773. 100 indexed citations
19.
Addla, Dinesh, Siqi Wen, Wei‐Wei Gao, et al.. (2016). Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents. MedChemComm. 7(10). 1988–1994. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amr Hassan Breakdown of academic impact, for papers by Parisa Ghanbari Breakdown of academic impact, for papers by Yasuo Nakayama Breakdown of academic impact, for papers by Badriya Baig Breakdown of academic impact, for papers by Birte Plitzko Breakdown of academic impact, for papers by Md. Saiful Islam Breakdown of academic impact, for papers by Fátima Liliana Monteiro Breakdown of academic impact, for papers by Xiaowen Zou
Rankless by CCL
2026